BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 29894766)

  • 1. Prion-like propagation of α-synuclein in the gut-brain axis.
    Chen Y; Shao Q; Yuan YH; Chen NH
    Brain Res Bull; 2018 Jun; 140():341-346. PubMed ID: 29894766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut-to-Brain α-Synuclein Transmission in Parkinson's Disease: Evidence for Prion-like Mechanisms.
    Chen M; Mor DE
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
    O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Neural Gut-Brain Axis of Pathological Protein Aggregation in Parkinson's Disease and Its Counterpart in Peroral Prion Infections.
    Beekes M
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys.
    Li X; Yang W; Li X; Chen M; Liu C; Li J; Yu S
    Neurosci Lett; 2020 Jan; 716():134640. PubMed ID: 31759083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut?
    Kujawska M; Jodynis-Liebert J
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.
    Manfredsson FP; Luk KC; Benskey MJ; Gezer A; Garcia J; Kuhn NC; Sandoval IM; Patterson JR; O'Mara A; Yonkers R; Kordower JH
    Neurobiol Dis; 2018 Apr; 112():106-118. PubMed ID: 29341898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice.
    Kishimoto Y; Zhu W; Hosoda W; Sen JM; Mattson MP
    Neuromolecular Med; 2019 Sep; 21(3):239-249. PubMed ID: 31079293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
    Dogra N; Mani RJ; Katare DP
    Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut dysfunction in Parkinson's disease.
    Mukherjee A; Biswas A; Das SK
    World J Gastroenterol; 2016 Jul; 22(25):5742-52. PubMed ID: 27433087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gut and Parkinson's Disease: Hype or Hope?
    Scheperjans F; Derkinderen P; Borghammer P
    J Parkinsons Dis; 2018; 8(s1):S31-S39. PubMed ID: 30584161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease.
    Anis E; Xie A; Brundin L; Brundin P
    Trends Endocrinol Metab; 2022 Feb; 33(2):147-157. PubMed ID: 34949514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Movement of prion-like α-synuclein along the gut-brain axis in Parkinson's disease: A potential target of curcumin treatment.
    Chetty D; Abrahams S; van Coller R; Carr J; Kenyon C; Bardien S
    Eur J Neurosci; 2021 Jul; 54(2):4695-4711. PubMed ID: 34043864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linking for the analysis of α-synuclein in the enteric nervous system.
    Corbillé AG; Neunlist M; Derkinderen P
    J Neurochem; 2016 Dec; 139(5):839-847. PubMed ID: 27637918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease from the gut.
    Liddle RA
    Brain Res; 2018 Aug; 1693(Pt B):201-206. PubMed ID: 29360467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis.
    Claudino Dos Santos JC; Lima MPP; Brito GAC; Viana GSB
    Ageing Res Rev; 2023 Feb; 84():101812. PubMed ID: 36455790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence.
    Pellegrini C; Antonioli L; Colucci R; Ballabeni V; Barocelli E; Bernardini N; Blandizzi C; Fornai M
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1407-14. PubMed ID: 26499757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-Dependent Alpha-Synuclein Accumulation and Phosphorylation in the Enteric Nervous System in a Transgenic Mouse Model of Parkinson's Disease.
    Zhong CB; Chen QQ; Haikal C; Li W; Svanbergsson A; Diepenbroek M; Li JY
    Neurosci Bull; 2017 Oct; 33(5):483-492. PubMed ID: 28924920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system.
    Noorian AR; Rha J; Annerino DM; Bernhard D; Taylor GM; Greene JG
    Neurobiol Dis; 2012 Oct; 48(1):9-19. PubMed ID: 22722052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies.
    Perez-Pardo P; Kliest T; Dodiya HB; Broersen LM; Garssen J; Keshavarzian A; Kraneveld AD
    Eur J Pharmacol; 2017 Dec; 817():86-95. PubMed ID: 28549787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.